CommercialCoverageHigh impact
Lymphedema (CPB 0069, reviewed 2026-02-25)
Aetna·Physical Therapy, Oncology, General Surgery +1 more·Medical Policy
Effective date
Feb 25, 2026
We identified it
Aug 17, 2026
Summary
Aetna updated its lymphedema clinical policy (CPB 0069) effective 2026-02-25, establishing strict medical necessity criteria for coverage of complex decongestive physiotherapy, pneumatic compression devices (with and without calibrated gradient pressure), static compression sleeves, and excisional procedures. The policy requires documented compliance history, 4-week conservative therapy trials before device approval, and specific clinical findings (hyperkeratosis, papillomatosis, elephantiasis deformity, skin breakdown, or measured persistence) to justify coverage. Key change: pneumatic compression devices are only medically necessary when conservative therapy shows NO significant improvement after 4 weeks.
Action Required
By March 25, 2026: Billing team must implement verification requirements for all lymphedema treatment claims submitted to Aetna. (1) For Complex Decongestive Physiotherapy: Obtain prior authorization documentation confirming member has intractable lymphedema, ulceration evidence, OR prior admission for cellulitis/ulceration AND verified compliance history. (2) For Pneumatic Compression Devices (non-calibrated): Verify 4-week trial of conservative therapy (compression garment, exercise, elevation, manual lymphatic drainage if available) with detailed measurements showing NO significant improvement before authorizing device. (3) For Pneumatic Compression Devices (calibrated gradient): Confirm lymphedema extends to chest/trunk/abdomen AND 4-week trial of standard device failed before authorizing. (4) For Static Compression Sleeves: Confirm intractable arm lymphedema diagnosis and limit initial authorization to 3 sleeves/gloves per arm, then 2 replacements per arm every 6 months. (5) For Excisional Procedures (debulking/liposuction): Obtain prior authorization confirming chronic refractory lymphedema diagnosis. Update billing software to require: evidence of clinical findings (hyperkeratosis, papillomatosis, elephantiasis, skin breakdown with lymphorrhea, or measurement confirmation with documented etiology), 4-week trial documentation with specific treatment components (compression specifications minimum pressure requirements, exercise logs, elevation compliance, MLD notes), and reassessment measurements at 1-week intervals. Add to encounter templates: checkbox for compliance verification, clinical finding documentation fields, conservative therapy trial confirmation. Claims submitted without required trial documentation or showing improvement during trial will be denied. For members without DME benefits: lymphedema pumps covered ONLY for arm lymphedema due to mastectomy for breast cancer; static compression sleeves covered ONLY for arm lymphedema due to mastectomy.